Kronos Bio, Inc. Total Liabilities and Equity
Kronos Bio, Inc. had Total Liabilities and Equity of $108.14 million as of 2025-03-31, per its 10-Q filed 2025-05-08.
Financial Statements › Balance Sheet
us-gaap:LiabilitiesAndStockholdersEquity · last filed 2025-05-08
- 2025-03-31: Liabilities and Equity $108.14M.
- 2024-12-31: Liabilities and Equity $124.36M.
- 2024-09-30: Liabilities and Equity $150.02M.
- 2024-06-30: Liabilities and Equity $164.27M.
| Period end | Liabilities and Equity |
|---|---|
| 2025-03-31 | $108.14M 10-Q · filed 2025-05-08 |
| 2024-12-31 | $124.36M 10-Q · filed 2025-05-08 |
| 2024-09-30 | $150.02M 10-Q · filed 2024-11-13 |
| 2024-06-30 | $164.27M 10-Q · filed 2024-08-08 |
| 2024-03-31 | $182.98M 10-Q · filed 2024-05-09 |
| 2023-12-31 | $213.28M 10-K · filed 2025-03-18 |
| 2023-09-30 | $237.99M 10-Q · filed 2023-11-13 |
| 2023-06-30 | $260.62M 10-Q · filed 2023-08-08 |
| 2023-03-31 | $289.02M 10-Q · filed 2023-05-10 |
| 2022-12-31 | $294.94M 10-K · filed 2024-03-21 |
| 2022-09-30 | $317.67M 10-Q · filed 2022-11-08 |
| 2022-06-30 | $341.22M 10-Q · filed 2022-08-04 |
| 2022-03-31 | $365.86M 10-Q · filed 2022-05-04 |
| 2021-12-31 | $391.48M 10-K · filed 2023-03-15 |
| 2021-09-30 | $447.53M 10-Q · filed 2021-11-09 |
| 2021-06-30 | $471.74M 10-Q · filed 2021-08-12 |
| 2021-03-31 | $487.96M 10-Q · filed 2021-05-11 |
| 2020-12-31 | $511.96M 10-K · filed 2022-02-24 |
| 2020-09-30 | $262.56M 10-Q · filed 2020-11-18 |
| 2019-12-31 | $102.69M 10-K · filed 2021-03-23 |